Telemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study

Inclusion Criteria

• •Adult oncology or haematology patients currently receiving systemic anti-cancer therapy (SACT).
• •New-onset dermatologic toxicity consistent with a recognised adverse effect of the administered SACT.
• •Skin toxicity severity graded ≤ Grade 2 in accordance with UKONS assessment criteria.
• •Clinically stable condition not requiring urgent in-person evaluation.
• •Access to, and ability to use, a smartphone or computer with adequate internet connectivity to participate in telemedicine consultations.